Blood biomarkers for evaluation of perinatal encephalopathy: state of the art
Related Experiment Video
Updated: Feb 15, 2026

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Ernest M Graham1,2, Allen D Everett2,3, Jean-Christophe Delpech4
1Division of Maternal-Fetal Medicine, Department of Gynecology and Obstetrics.
Insights
Point-of-care biomarkers are poised to transform neonatal intensive care unit (NICU) care for infants with brain injuries. Recent findings show promise in predicting injury and guiding treatment for conditions like hypoxic-ischemic encephalopathy (HIE).
Area of Science:
- Biomarker science
- Neonatal neurology
- Clinical diagnostics
Background:
- Neonatal intensive care unit (NICU) care is evolving with advancements in biomarker science.
- Infants with neonatal brain injuries represent a key area for improved clinical management.
- Point-of-care biomarker analysis offers rapid insights into brain injury.
Purpose of the Study:
- To provide an update on recent progress in neonatal brain injury biomarkers.
- To highlight key findings from the past 18 months of research.
- To discuss the potential impact of biomarkers on clinical care.
Main Methods:
- Review of recent publications (past 18 months) on neonatal brain injury biomarkers.
- Analysis of non-brain markers (cardiac, asphyxia) in hypoxic-ischemic encephalopathy (HIE).
- Investigation of biomarker utility in animal models (piglet hypoxia-ischemia).
Main Results:
- Non-brain markers and plasma metabolite scores aid in predicting injury after HIE.
- A systemic proinflammatory cytokine surge identified post-hypothermia in neonatal piglet models.
- Newly identified biomarkers include osteopontin, activin A, NGAL, secretoneurin, Tau, and neurofilament light protein.
- Brain-based biomarkers show varying predictive capabilities for short-term and long-term outcomes.
Conclusions:
- Neonatal brain biomarker research is in its early stages.
- Significant advancements are anticipated in the field.
- Biomarkers hold potential to revolutionize the management of neonatal brain injuries.
Purpose Of Review:
The rapid progress in biomarker science is on the threshold of significantly changing clinical care for infants in the neonatal ICU. Infants with neonatal brain injuries will likely be the first group whose management is dramatically altered with point-of-care, rapidly available brain biomarker analysis. Providing an interim update on progress in this area is the purpose of this review.
Recent Findings:
Highlighted findings from the past 18 months of publications on biomarkers in neonatal brain injury include; Specific nonbrain markers of cardiac health and global asphyxia continue to provide information on brain injury after hypoxic-ischemic encephalopathy (HIE). Prediction of injury in the piglet hypoxia-ischemia model is improved with the use of a combination score of plasma metabolites. In a neonatal piglet model of perinatal hypoxia-ischemia, a systemic proinflammatory surge of cytokines has been identified after rewarming from therapeutic hypothermia. New biomarkers identified recently include osteopontin, activin A, neutrophil gelatinase-associated lipocalin, secretoneurin, Tau and neurofilament light protein. Brain-based biomarkers differ in their ability to predict short-term in-hospital outcomes and long-term neurologic deficits.
Summary:
Neonatal brain biomarker research is currently in its very early development with major advances still to be made.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Self-Evaluation: Self-Enhancement and Self-Verification
Composition of Blood
Formed elements constitute the remaining 45% of the blood volume. These...
Blood Flow
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Blood Pressure

